When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - FDA OKs expanded use of Karyopharm's selinexor
Karyopharm Therapeutics Inc.
Under accelerated review status, the FDA has approved Karyopharm Therapeutics' (KPTI+4.3%) Xpovio (selinexor) for the treatment of adults with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from follicular lymphoma, after at least two lines of systemic therapy.
More news on: Karyopharm Therapeutics Inc., Healthcare stocks news, Stocks on the move,